Cybrexa was founded by physician-scientists and an experienced management team that has built numerous successful life sciences ventures. They are an oncology-focused platform technology company that enables antigen-independent targeting of tumors and metastases with deep tissue penetration for small molecule anti-cancer drugs. They’re passionate about bringing new treatment options to help more cancer patients live longer, more fulfilling lives.